We performed two in silico experiments to assess the detection limits of different deconvolution algorithms. In the first experiment (Supplementary Fig. 6 ), we used the same cell line GEPs described above to compare CIBERSORT and RLR with five other GEP deconvolution methods4 (link)–8 (link). We evaluated detection limit using Jurkat cells (spike-in concentrations of 0.5%, 1%, 2.5%, 5%, 7.5%, and 10%), whose reference GEP (median of three replicates in GSE11103) was added into randomly created background mixtures of the other three blood cell lines. Five mixtures were created for each spike-in concentration. Predicted Jurkat fractions were assessed in the presence of differential tumor content, which we simulated by adding HCT116 (described above) in ten even increments, from 0% to 90%. Of note, we also used the same marker or signature genes described for simulated tumors (above). In a second experiment (Supplementary Fig. 7a ), we compared CIBERSORT with QP5 (link), LLSR4 (link), PERT6 (link), and RLR. We spiked naïve B cell GEPs from the leukocyte signature matrix into four random background mixtures of the remaining 21 leukocyte subsets in the signature matrix. The same background mixtures were used for each spike-in. We also tested the addition of unknown content by adding defined proportions (0 to 90%) of randomly permuted expression values from a naïve B cell reference transcriptome (median expression profile from samples used to build LM22, Supplementary Table 1 ). We then repeated this analysis for each of the remaining leukocyte subsets in LM22 (Supplementary Fig. 7b ).
>
Procedures
>
Laboratory Procedure
>
Leukocyte Count
Leukocyte Count
Leukocyte Count: A quantitative assessment of the number of white blood cells (leukocytes) present in a sample of blood.
This measurement is commonly used to evaluate overall health, detect and monitor infections, and assess the body's immune response.
Accurately determining leukocyte count is crucial for a wide range of medical and research applications, including the diagnosis and management of hematological disorders, infectious diseases, and inflammatory conditions.
PubCompare.ai's AI-driven platform can help optimize your leukocyte count research by effortlessly locating the most relevant protocols from literature, pre-prints, and patents, enabling intelligent comparisons to identify the best protocols and products.
Unleash the power of PubCompare.ai to enhance your research reproducibility and accuracy, and take your leukocyte count studies to new heigths.
This measurement is commonly used to evaluate overall health, detect and monitor infections, and assess the body's immune response.
Accurately determining leukocyte count is crucial for a wide range of medical and research applications, including the diagnosis and management of hematological disorders, infectious diseases, and inflammatory conditions.
PubCompare.ai's AI-driven platform can help optimize your leukocyte count research by effortlessly locating the most relevant protocols from literature, pre-prints, and patents, enabling intelligent comparisons to identify the best protocols and products.
Unleash the power of PubCompare.ai to enhance your research reproducibility and accuracy, and take your leukocyte count studies to new heigths.
Most cited protocols related to «Leukocyte Count»
B-Lymphocytes
BLOOD
Cell Lines
Cytosol
Genes
Jurkat Cells
Leukocyte Count
Leukocytes
Neoplasms
Transcriptome
The Metabochip was designed by representatives of the Body Fat Percentage [9] (link), CARDIoGRAM (coronary artery disease and myocardial infarction) [10] (link), DIAGRAM (type 2 diabetes) [11] (link), GIANT (anthropometric traits) [3] (link), [12] (link), [13] (link), Global Lipids Genetics (lipids) [4] (link), HaemGen (hematological measures) [14] (link), ICBP (blood pressure) [15] (link), MAGIC (glucose and insulin) [16] (link)–[18] (link), and QT-IGC (QT interval) [19] (link), [20] (link) GWAS meta-analysis consortia. The array is comprised of SNPs selected across two tiers of traits (Table 1 ). Tier 1 is comprised of eleven traits deemed to be of primary interest: type 2 diabetes (T2D), fasting glucose, coronary artery disease and myocardial infarction (CAD/MI), low density lipoprotein (LDL) cholesterol, high density lipoprotein (HDL) cholesterol, triglycerides, body mass index (BMI), systolic and diastolic blood pressure, QT interval, and waist-to-hip ratio adjusted for BMI (WHR). Tier 2 is comprised of twelve traits of secondary interest: fasting insulin, 2-hour glucose, glycated hemoglobin (HbA1c), T2D age of diagnosis, early onset T2D (diagnosis age<45 years), waist circumference adjusted for BMI, height, body fat percentage, total cholesterol, platelet count, mean platelet volume, and white blood cell count.
We included three design classes of SNPs on the Metabochip (Table 2 ):
In total, 217,695 SNPs were chosen for the array (Table 2 ). 20,970 SNPs (9.6%) failed during the assay manufacturing process, resulting in 196,725 SNPs available for genotyping. A summary file annotating each Metabochip SNP with ascertainment criteria, SNP assay, a list of unintended duplicate SNPs (Supplementary Table S4 ), and reference strand orientation for alleles is provided at http://www.sph.umich.edu/csg/kang/MetaboChip/ .
We included three design classes of SNPs on the Metabochip (
In total, 217,695 SNPs were chosen for the array (
Full text: Click here
ADCAD1
Alleles
Biological Assay
Blood Pressure
Body Fat
Cholesterol
Diabetes Mellitus, Non-Insulin-Dependent
Diagnosis
Genome-Wide Association Study
Gigantism
Glucose
Hemoglobin, Glycosylated
High Density Lipoprotein Cholesterol
Index, Body Mass
Insulin
Leukocyte Count
Lipids
Low-Density Lipoproteins
Platelet Counts, Blood
Pressure, Diastolic
Single Nucleotide Polymorphism
Systole
Triglycerides
Volumes, Mean Platelet
Waist-Hip Ratio
Waist Circumference
Arteries
Blood Gas Analysis
Cells
Chest
Clinical Protocols
Emergencies
Ethics Committees, Research
Homo sapiens
Infection
Inpatient
Lactates
Leukocyte Count
Operative Surgical Procedures
Patients
Physicians
Rate, Heart
Respiratory Rate
Resuscitation
Saturation of Peripheral Oxygen
Septicemia
Serum
Severe Sepsis
Systemic Inflammatory Response Syndrome
Systolic Pressure
Venous Catheter, Central
Data are presented as median and range. Grouping of the variables age, tumour type, performance status (ECOG), haemoglobin, white cell count and albumin was carried out using standard thresholds (Paesmans et al, 1997; Herndon et al, 1999 (link)). C-reactive protein concentrations were also grouped (⩽10/>10 mg l−l) as previously described (O'Gorman et al, 2000 (link)). Prognostic scores were constructed by assigning one point for each of the following criteria: stage IV, ECOG 2–4, albumin <35 g l−l and C-reactive protein >10 mg l−l. Cumulative scores were obtained by combining C-reactive protein with each of the other variables.
Univariate survival analysis was performed using the Kaplan–Meier method. Multivariate survival analysis and calculation of hazard ratios (HR) were performed using the Cox regression analysis with prognostic scores as covariates. Deaths up to 31 January 2003 were included in the analysis. Analysis was performed using SPSS software (SPSS Inc., Chicago, IL, USA).
Univariate survival analysis was performed using the Kaplan–Meier method. Multivariate survival analysis and calculation of hazard ratios (HR) were performed using the Cox regression analysis with prognostic scores as covariates. Deaths up to 31 January 2003 were included in the analysis. Analysis was performed using SPSS software (SPSS Inc., Chicago, IL, USA).
Full text: Click here
Albumins
C Reactive Protein
Electrocorticography
Hemoglobin
Leukocyte Count
Neoplasms
Alexa Fluor 555
Antibodies, Anti-Idiotypic
Binding Sites
BLOOD
Blood Volume
Cells
Centrifugation
Chloride, Ammonium
Common Cold
Cytokeratin
DAPI
Erythrocytes
Goat
Leukocyte Count
Leukocytes
Malignant Neoplasms
Methanol
Microscopy
Monoclonal Antibodies
Mus
paraform
Patients
Retention (Psychology)
Serum
Most recents protocols related to «Leukocyte Count»
All patients admitted to our hospital received a basic oral health check, including OHAT, by a dental hygienist to identify those requiring dental treatment and oral care. OHAT was developed for regular oral assessment and protocolisation of oral care, in an attempt to provide equitable, high-quality oral care, regardless of the personnel administering care4 (link) and for objective assessment of the oral environment in clinical practice.
Patients with swallowing dysfunction are commonly referred to the Ear, Nose and Throat department for VE and VF, followed by treatment and rehabilitation.
This study included 24 patients (7 men and 17 women; age range: 64–97 years; average age: 86 years) who were examined by OHAT, VE and VF at Fukuoka Dental College Hospital between April 2014 and October 2019. Patients with head and neck cancers were excluded from the study, as these conditions may affect the oral environment.
A flow chart of patient selection is shown inFigure 1 .
![]()
A diagnosis of pneumonia was made in cases fulfilling the following criteria: chest X-ray or chest computed tomography (CT) showing an alveolar infiltration shadow, with a fever of 37.5°C or higher and an abnormally high C-reactive protein level, a peripheral white blood cell count of more than 9000/µL and/or the presence of any two or more airway symptoms, such as sputum. We evaluated the associations of the OHAT score with VE and VF and compared the associations between patients with no or only a single episode of pneumonia (no/single-pneumonia episode group) and patients with multiple pneumonia episodes (multiple-pneumonia episode group).
Patients with swallowing dysfunction are commonly referred to the Ear, Nose and Throat department for VE and VF, followed by treatment and rehabilitation.
This study included 24 patients (7 men and 17 women; age range: 64–97 years; average age: 86 years) who were examined by OHAT, VE and VF at Fukuoka Dental College Hospital between April 2014 and October 2019. Patients with head and neck cancers were excluded from the study, as these conditions may affect the oral environment.
A flow chart of patient selection is shown in
Flow chart of patient selection.
Cancer of Head and Neck
Chest
C Reactive Protein
Dental Care
Dental Health Services
Diagnosis
Fever
Hygienist, Dental
Leukocyte Count
Nose
Patients
Pharynx
Pneumonia
Quality of Health Care
Radiography, Thoracic
Rehabilitation
Sputum
Woman
X-Ray Computed Tomography
The following coagulation assays (reagent and unit in parenthesis) in citrated (3.2%) plasma were analyzed at the local Central Coagulation Laboratory (HUSLAB of Helsinki University Hospital): FVIII (FVIII:C one-stage clotting assay [IU/dl], pathromtin SL and FVIII deficient plasma), fibrinogen (Clauss method [g/l], HemosIL Q.F.A.Thrombin, Werfen, Barcelona, Spain; D-dimer [mg/l] HemosIL D-Dimer HS 500), antithrombin (AT [%], a chromogenic assay Berichrom Antithrombin III), thrombin time ([s], BC Thrombin reagent, Siemens), activated partial thromboplastin time (APTT [s], Actin FSL®, Siemens) and anti-FXa activity (anti-FXa [IU/ml], HemosIL Liquis Anti-Xa, Mediq Suomi Oy). We acquired data of these coagulation markers preoperatively and from the days 1, 2, 3, 7, 14, 30, 90, and 12 months after the operation, if available.
In addition, we measured the dynamics of white blood cell (WBC) count, C-reactive protein (CRP, mg/l), and platelet count (109/l) from the same time points. Preoperative plasma values of prothrombin time (Medirox Owren's PT [%] Medirox, Nyköping, Sweden), FXIII (F-XIII, %), VWF antigen (VWF:Ag, %) and VWF glycoprotein GPIb binding activity (VWF:Act, %), homocysteine (Hcyst, µmol/l), low-density lipoprotein (mmol/l), and triglycerides (Trigly, mmol/l) were collected. Additionally, patients were screened for protein C and S deficiencies, antiphospholipid antibodies as well as Factor V Leiden and FII G20210A mutations.
In addition, we measured the dynamics of white blood cell (WBC) count, C-reactive protein (CRP, mg/l), and platelet count (109/l) from the same time points. Preoperative plasma values of prothrombin time (Medirox Owren's PT [%] Medirox, Nyköping, Sweden), FXIII (F-XIII, %), VWF antigen (VWF:Ag, %) and VWF glycoprotein GPIb binding activity (VWF:Act, %), homocysteine (Hcyst, µmol/l), low-density lipoprotein (mmol/l), and triglycerides (Trigly, mmol/l) were collected. Additionally, patients were screened for protein C and S deficiencies, antiphospholipid antibodies as well as Factor V Leiden and FII G20210A mutations.
Full text: Click here
Actins
Activated Partial Thromboplastin Time
Antigens
Antiphospholipid Antibodies
Antithrombin III
azo rubin S
Biological Assay
Coagulation, Blood
C Reactive Protein
factor V Leiden
fibrin fragment D
Fibrinogen
Glycoproteins
Heparin, Low-Molecular-Weight
Homocysteine
Leukocyte Count
Low-Density Lipoproteins
Mutation
Patients
Plasma
Platelet Counts, Blood
Protein C
Tests, Blood Coagulation
Thrombin
Times, Prothrombin
Times, Reptilase
Triglycerides
The CII was defined as the ratio of white blood cell (WBC) count (×109/L) to lymphocyte proportion (%). The optimal threshold of CII was calculated using the X-tile software (Version 3.6.1, Yale University, New Haven, CT). Ultimately, 43.1 was determined as the optimal cutoff value of CII in the training cohort and was used to stratify patients in subsequent analyses.
Full text: Click here
Leukocyte Count
Lymphocyte
Patients
Descriptive statistics were used to present the patients’ characteristics and clinical parameters with mean ± standard deviation or frequency. The chi-square test was employed for frequency data, presented as n and %.
The threshold for anemia was hemoglobin < 12 g/dl in female patients and < 13 g/dl in male patients. ID was defined by the threshold for ferritin as < 30 ng/ml with normal levels of CRP and ferritin < 100 ng/ml with CRP levels > 5 mg/l. The reference cutoffs were based on reference ranges that were either previously established by clinical research or taken from the local laboratory.
The relevance for survival was investigated for clinical parameters associated with outcome in SSc including sex, age, type of SSc, presence of ILD [15 (link)], DLCO ≤ 65% predicted [5 (link)], and PVR ≥ 2 WU [10 (link)]. Furthermore, parameters associated with iron metabolism or inflammation including CRP and white blood cell count were compared between the groups. The Mann-Whitney U test was employed to compare the clinical characteristics between the patient groups with HRC > 2% and ≤ 2%.
The prognostic values for survival were investigated by uni- and multivariable Cox regression analysis. Death due to any cause, date of lung transplantation, or date of last contact was recorded for survival at follow-up and compared to the time of the first evaluation (baseline). Univariable categorial analysis was performed by Kaplan-Meier analysis. A multivariable Cox model was performed including all variables, which were significantly associated with survival (p < 0.05) in the univariable log rank tests. The combined independent parameters for risk assessment were compared with known risk stratification tools REVEAL [16 (link)], REVEAL 2.0 [17 (link)], COMPERA [18 ], and the French risk assessment strategy [19 ]. p-values < 0.05 were considered as statistically significant. IBM SPSS V 27.0 was used to conduct all analyses (IBM Corp. Released 2020. IBM SPSS Statistics for Macintosh, version 27.0. Armonk, NY: IBM Corp.).
The threshold for anemia was hemoglobin < 12 g/dl in female patients and < 13 g/dl in male patients. ID was defined by the threshold for ferritin as < 30 ng/ml with normal levels of CRP and ferritin < 100 ng/ml with CRP levels > 5 mg/l. The reference cutoffs were based on reference ranges that were either previously established by clinical research or taken from the local laboratory.
The relevance for survival was investigated for clinical parameters associated with outcome in SSc including sex, age, type of SSc, presence of ILD [15 (link)], DLCO ≤ 65% predicted [5 (link)], and PVR ≥ 2 WU [10 (link)]. Furthermore, parameters associated with iron metabolism or inflammation including CRP and white blood cell count were compared between the groups. The Mann-Whitney U test was employed to compare the clinical characteristics between the patient groups with HRC > 2% and ≤ 2%.
The prognostic values for survival were investigated by uni- and multivariable Cox regression analysis. Death due to any cause, date of lung transplantation, or date of last contact was recorded for survival at follow-up and compared to the time of the first evaluation (baseline). Univariable categorial analysis was performed by Kaplan-Meier analysis. A multivariable Cox model was performed including all variables, which were significantly associated with survival (p < 0.05) in the univariable log rank tests. The combined independent parameters for risk assessment were compared with known risk stratification tools REVEAL [16 (link)], REVEAL 2.0 [17 (link)], COMPERA [18 ], and the French risk assessment strategy [19 ]. p-values < 0.05 were considered as statistically significant. IBM SPSS V 27.0 was used to conduct all analyses (IBM Corp. Released 2020. IBM SPSS Statistics for Macintosh, version 27.0. Armonk, NY: IBM Corp.).
Full text: Click here
Anemia
Ferritin
Health Risk Assessment
Hemoglobin
Inflammation
Iron
Leukocyte Count
Lung Transplantation
Males
Metabolism
Patients
Woman
Preoperative factors were collected, including age, sex, recent major cardiovascular procedure (within 3 months), coronary artery disease, cerebral vascular events, chronic lung disease, essential hypertension, dyslipidemia, liver cirrhosis, atrial fibrillation, type 2 diabetes mellitus, end-stage renal disease with dialysis (both hemodialysis and peritoneal dialysis), and regular use of antiplatelet or anticoagulant agents. The major cardiovascular procedures included coronary arterial bypass, coronary arterial angioplasty/stenting, cardiac valvular surgery, aortic surgery, and peripheral arterial surgery. Preoperative blood cell counts included white cell counts, differential counts (immature band form white cell) [15 (link)], platelet counts, the neutrophil-to-lymphocyte ratio (NLR) [16 (link)], and hemoglobin levels. Preoperative blood biochemistry results included serum levels of albumin, alanine aminotransferase (ALT), bilirubin, and creatinine. The coagulation test included the prothrombin time (PT) and was expressed by the international normalized ratio (INR). Preoperative shock status was defined as the requirement for vasopressors or inotropes. The types of AMI were determined by preoperative contrast CT scans.
Full text: Click here
Angioplasty
Angioplasty, Balloon, Coronary
Anticoagulants
Aorta
Arteries
Artery, Coronary
Atrial Fibrillation
Bilirubin
BLOOD
Cardiovascular System
Cells
Cerebrovascular Accident
Coronary Arteriosclerosis
Coronary Artery Bypass Surgery
Creatinine
D-Alanine Transaminase
Diabetes Mellitus, Non-Insulin-Dependent
Dialysis
Disease, Chronic
Dyslipidemias
Essential Hypertension
Hemodialysis
Hemoglobin
Inotropism
International Normalized Ratio
Kidney Failure, Chronic
Leukocyte Count
Liver Cirrhosis
Lung
Lung Diseases
Lymphocyte
Neutrophil
Neutrophil Band Cells
Operative Surgical Procedures
Peritoneal Dialysis
Platelet Counts, Blood
Serum Albumin
Shock
Surgical Procedure, Cardiac
Tests, Blood Coagulation
Times, Prothrombin
Vasoconstrictor Agents
X-Ray Computed Tomography
Top products related to «Leukocyte Count»
Sourced in Japan, Germany, United Kingdom, United States, Brazil
The XE-2100 is a hematology analyzer designed for automated blood cell analysis. It provides comprehensive analysis of various blood cell types, including red blood cells, white blood cells, and platelets. The XE-2100 is capable of performing a wide range of hematological tests and measurements to support clinical decision-making.
Sourced in Japan, Germany, United States, China, Portugal, Denmark
The XE-5000 is a fully automated hematology analyzer developed by Sysmex. The XE-5000 is designed to perform complete blood count (CBC) and white blood cell differential analysis on biological samples.
Sourced in United States, Germany, United Kingdom, China, Canada, Japan, Italy, France, Belgium, Switzerland, Singapore, Uruguay, Australia, Spain, Poland, India, Austria, Denmark, Netherlands, Jersey, Finland, Sweden
The FACSCalibur is a flow cytometry system designed for multi-parameter analysis of cells and other particles. It features a blue (488 nm) and a red (635 nm) laser for excitation of fluorescent dyes. The instrument is capable of detecting forward scatter, side scatter, and up to four fluorescent parameters simultaneously.
Sourced in United States
The Biochemistry Panel Plus analyzer discs by Abaxis are designed for clinical laboratory use to perform quantitative analysis of various analytes in biological samples. The discs provide a compact and integrated platform for automated processing and testing.
Sourced in United States, Germany, United Kingdom, Belgium, China, Australia, France, Japan, Italy, Spain, Switzerland, Canada, Uruguay, Netherlands, Czechia, Jersey, Brazil, Denmark, Singapore, Austria, India, Panama
The FACSCanto II is a flow cytometer instrument designed for multi-parameter analysis of single cells. It features a solid-state diode laser and up to four fluorescence detectors for simultaneous measurement of multiple cellular parameters.
Sourced in United States
The Hemavet 950 is a compact, automated hematology analyzer designed for comprehensive blood cell analysis. It provides accurate and reliable measurements of various blood parameters, including red blood cells, white blood cells, and platelet counts.
Sourced in Japan, Germany, United States, France, Switzerland, China
The XN-9000 is a hematology analyzer manufactured by Sysmex. It is designed to perform complete blood count (CBC) analysis, including the determination of red blood cells, white blood cells, and platelets. The XN-9000 utilizes advanced technology to provide accurate and reliable results.
Sourced in China, Germany, United States
The BC-2800Vet is a compact, automated hematology analyzer designed for veterinary use. It provides a comprehensive analysis of blood samples, including complete blood count (CBC) parameters.
Sourced in United States, Germany, United Kingdom, France, Canada, Belgium, Australia, Italy, Spain, Switzerland, China, Netherlands, Finland, Japan, Jersey, Lao People's Democratic Republic
FACSDiva software is a user-friendly flow cytometry analysis and data management platform. It provides intuitive tools for data acquisition, analysis, and reporting. The software enables researchers to efficiently process and interpret flow cytometry data.
Sourced in Japan, Germany, United States, India
The KX-21 is a compact, automated hematology analyzer designed for routine blood cell analysis. It provides a rapid and accurate assessment of common blood parameters, including red blood cell count, white blood cell count, and platelet count.